Press Release Oncology Venture is issuing 925,925 shares under its convertible note agreement with Negma Group LTD and Park Partners GB

NEXT STORY
The Global Healthcare CRO Market size is expected to reach $57.1 billion by 2025, rising at a market growth of 6.8% CAGR during the forecast period
PREV STORY
Revive Therapeutics Partners with Complete Phytochemical Solutions to Advance Research Initiatives for Psilocybin-Based Pharmaceutical Products
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Soluble Biotech Announces First Contract with a Major Pharmaceutical Company for Protein Expression and Solubility Studies

author_avatar
NASDAQ Market News

Active Biotech and NeoTX today announce that the first patient has been enrolled in the phase IIa clinical trial of naptumomab estafenatox in combination with docetaxel in patients with advanced non-small cell lung cancer (NSCLC)

author_avatar
NASDAQ Market News

Endoscope Market

author_avatar
NASDAQ Market News